REACH Trial Outcomes
The REACH trial demonstrated significant short-term improvements in glycemic control, medication adherence, and dietary habits through 12 months, but these effects were not sustained at 15-month follow-up, indicating that text messaging alone is insufficient for long-term diabetes management. 1
Primary Glycemic Control Outcomes
The REACH (Rapid Education/Encouragement and Communications for Health) trial showed a modest but statistically significant reduction in HbA1c at 6 months of -0.31% (95% CI -0.61%, -0.02%) 1. This effect was substantially larger among participants with poor baseline control (HbA1c ≥8.5%), achieving -0.74% reduction (95% CI -1.26%, -0.23%) 1.
Critically, by 15 months (3 months post-intervention), treatment effects were no longer significant for any outcome, demonstrating that the benefits dissipated once the text messaging intervention ceased 1.
Medication Adherence Results
REACH significantly improved medication adherence through the 12-month intervention period 1. The intervention successfully reduced barriers to medication adherence, though interestingly, this barrier reduction did not statistically mediate the observed outcome improvements 1. Like glycemic control, adherence benefits disappeared at 15-month follow-up.
Dietary Habits and Self-Care
The intervention improved dietary habits through 12 months 1. Self-care behaviors showed improvements during the active intervention phase, but these gains were not maintained after text messaging stopped at 12 months 1.
Diabetes Self-Efficacy
Self-efficacy improvements were observed through 6 months only 1. This represents the shortest duration of benefit among all measured outcomes, suggesting that confidence in diabetes management requires more sustained support than the intervention provided.
Long-Term Follow-Up Findings
The 15-month assessment revealed complete loss of treatment effects across all domains 1. This critical finding indicates that:
- Text messaging interventions require continuous delivery to maintain benefits
- More comprehensive interventions beyond texts alone are necessary for sustained diabetes management
- The intervention successfully engaged patients during active delivery but failed to create lasting behavioral change
Engagement and Feasibility
Despite the lack of sustained effects, REACH demonstrated exceptional feasibility:
- Retention exceeded 90% throughout the study 1
- Median response rate to interactive texts was 91% (interquartile range 75%, 97%) 1
- The intervention successfully engaged a highly vulnerable population: approximately half were racial/ethnic minorities, half were underinsured with household incomes <$35,000, and 11% were homeless 1
Importantly, there was no evidence of effect modification by race/ethnicity or socioeconomic disadvantage, demonstrating equitable effectiveness across diverse populations during the active intervention period 1.
Clinical Implications
The REACH trial provides strong evidence that tailored text messaging can produce meaningful short-term improvements in diabetes management among diverse, at-risk populations. However, the complete loss of benefits at 15 months definitively demonstrates that text messaging must be either continued indefinitely or combined with other sustained interventions to achieve lasting improvements in glycemic control, adherence, dietary habits, and self-efficacy 1.